Mutations in COL1A1 and COL1A2 Genes Associated with Osteogenesis Imperfecta (OI) Types I or III.
Abstract
Over 85% of osteogenesis imperfecta (OI) cases associates to mutations in procollagen type I genes (COL1A1 or COL1A2), however, no hot spots were linked to particular clinical phenotypes. The 8 patients whom were clinically diagnosed with OI are from Polish population with no ethnic background indicated. Six unpublished mutations were detected in eight patients diagnosed with OI. Genotypes for polymorphisms (Sp1 - rs1800012 and PvuII - rs412777), linked to bone formation and metabolism were also determined. In COL1A1 gene the mutations were found in exons 2, 22, 50 and in introns 13 and 51. In COL1A2 one mutation was identified in exon 22. Mutations of deletion type in COL1A1 that resulted in OI type I an effect neither on collagen type I secretion nor its intracellular accumulation were detected. Also, a single base substitution in I13 (c.904-9 G>T) was associated with OI type I. The OI type III was associated with single base change in I51 of COL1A1, possibly causing an exon skipping. Also, a missense mutation in COL1A2 changing Gly®Cys in the central part of triple helical domain of the collagen type I molecule caused OI type III. It affected secretion of heterotrimeric form of procollagen type I. However, no intracellular accumulation of procollagen chains could be detected. Mutation in COL1A2 affected its incorporation to procollagen type I. The results shall help in genetic counseling of OI patients and provide rational support in making by them and their families conscious, life important decisions.
References
Blades HZ, Arundel P, Carlino WA, Dalton A, Crook JS, Freeman JV, Bishop NJ (2010) Collagen gene polymorphisms influence risk, and bone mass acquisition during childhood and adolescent growth. Bone 47:989-994. DOI:10.1016/j.bone.2010.08.014.
Byers PH, Wallis GA, Willing MC (1991) Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet 28:433-442.
Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Res 25(1):181-187.
Dalgleish R (1998) The human collagen mutation database 1998. Nucleic Acids Res 26:253-255.
[database] Osteogenesis imperfecta & Ehlers-Danlos syndrome variant databases. Available from: http://www.le.ac.uk/ge/collagen/
Dehghan M, Pourahmad-Jaktaji R (2015) Sp1 binding site polymorphism of a collagen gene (rs 1800012) in women aged 45 and over and its association with bone density. Turk J Med Sci 45:644-650.
Di Lullo GA, Sweeney SM, Körkkö J, Ala-Kokko L, San Antonio JD (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 277:4223-4231. DOI:10.1074/jbc.M110709200
Forlino A, Cabral WA, Barnes AM Marini JC (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7:540-557. DOI: 10.1038/nrendo.2011.81
Galicka A (2012) Mutacje genów niekolagenowych we wrodzonej łamliwości kości – znaczenie produktów tych genów w biosyntezie kolagenu i patogenezie choroby. [Mutations of noncollagen genes in osteogenesis imperfecta-implications of the gene products in collagen biosynthesis and pathogenesis of disease]. Postepy Hig Med Dosw 66:359-371.
Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α1 gene. Nat Genet 14:203-205. DOI: 10.1038/ng1096-203
Katz J, Gong Y, Salmasinia D, Salmasinia D, Hou W, Burkley B, Ferreira P, Casanova O, Langaee TY, Moreb JS (2011) Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. Int J Oral Maxillofac Surg 40:605-611. DOI:10.1016/j.ijom.2011.02.002
Kurt-Sirin O, Yilmaz-Aydogan H, Uyar M, Seyhan M-F, Isbir T, Can A (2014) Combined effects of collagen type 1 alpha1 (COL1A1) Sp1 polymorphism and osteoporosis risk factors on bone mineral density in Turkish postmenopausal women. Gene 540:226-231. DOI:10.1016/j.gene.2014.02.028
Majka M, Janeczko M, Gozdzik J, Jarocha D, Auguściak-Duma A, Witecka J, Lesiak M, Koryciak-Komarska H, Sieroń AL, Pietrzyk JJ (2013) Cell therapy of patient with type III osteogenesis imperfecta caused by mutation in COL1A2 gene and unstable collagen type I. OJGEN 3:49-60. DOI: 10.4236/ojgen.2013.31006
Mann V, Hobson EE, Li B, Stewart TL, Grant SFA, Robins SP, Aspden RM, Ralston SH (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899-907. DOI:10.1172/JCI10347
Pace JM, Wiese M, Drenguis AS, Kuznetsova N, Leikin S, Schwarze U, Chen D, Mooney SH, Unger S, Byers PH (2008) Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta. J Biol Chem 283:16061-16067. DOI:10.1074/jbc.M801982200
Roughley PJ, Rauch F, Glorieux FH (2003) Osteogenesis imperfecta-clinical and molecular diversity. Eur Cell Mater 5:41-47.
Sezer S, Simsek N, Celik HT, Erden G, Ozturk G, Duzgun AP, Coskun F, Demircan K (2014) Association of collagen type 1 alpha 1 gene polymorphism with inguinal hernia. Hernia 18:507-512. DOI:10.1007/s10029-013-1147-y
Sillence DO, Rimoin DL (1978) Classification of osteogenesis imperfecta. Lancet 1:1041-1042.
Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16:101-116.
Stephen J, Shukla A, Dalal A, Girisha KM, Shah H, Gupta N, Kabra M, Dabadghao P, Hasegawa K, Tanaka H, Phadke SR (2014) Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta. Am J Med Genet A. 164A:1482-1489. DOI: 10.1002/ajmg.a.36481
Suuriniemi M, Kovanen V, Mahonen A, Alen M, Wang Q, Lyytikainen A, Cheng S (2006) COL1A1 Sp1 polymorphism associates with bone density in early puberty. Bone 39:591-597. DOI:10.1016/j.bone.2006.02.053
Tarnowski M, Sieron AL (2008) Wrodzona łamliwość kości – etiologia, charakterystyka, metody leczenia dzisiaj i w przyszłości. [Osteogenesis imperfecta-etiology, characteristics, current and future treatment.] Wiad Lek 61:166-172.
van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PGJ, van Rijn RR, Pals G (2011) Osteogenesis imperfecta: A Review with Clinical Examples. Mol Syndromol 2:1-20. DOI:000332228
van Dijk F, Sillence D (2014) Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A:1470-1481. DOI:10.1002/ajmg.a.36545
Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 155A:943-968. DOI:10.1002/ajmg.a.33909
Witecka J, Auguściak-Duma AM, Kruczek A, Szydło A, Lesiak M, Krzak M, Pietrzyk JJ, Mannikko M, Sieroń AL (2008) Two novel COL1A1 mutations in patients with osteogenesis imperfecta (OI) affect the stability of the collagen type I triple-helix. J Appl Genet 49:283-295. DOI:10.1007/BF03195625
Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Copyright for all published papers © stays with the authors.
Copyright for the journal: © Polish Biochemical Society.
